Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Dow
Boehringer Ingelheim
Express Scripts
Colorcon

Last Updated: June 27, 2022

Investigational Drug Information for L-Leucine


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug L-Leucine?

L-Leucine is an investigational drug.

There have been 30 clinical trials for L-Leucine. The most recent clinical trial was a Phase 3 trial, which was initiated on October 18th 2001.

The most common disease conditions in clinical trials are Neuroblastoma, Ganglioneuroblastoma, and Breast Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Roswell Park Cancer Institute, and IntraBio Inc.

Recent Clinical Trials for L-Leucine
TitleSponsorPhase
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA StudyNational Cancer Institute (NCI)Phase 1
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA StudyMayo ClinicPhase 1
A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type CIntraBio IncPhase 3

See all L-Leucine clinical trials

Clinical Trial Summary for L-Leucine

Top disease conditions for L-Leucine
Top clinical trial sponsors for L-Leucine

See all L-Leucine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Dow
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.